Boston Scientific Says Potential FTC Penalties Will Have No Material Impact
This article was originally published in The Gray Sheet
Executive Summary
Boston Scientific's potential liability for failure to supply Discovery intravascular ultrasound catheters to Hewlett-Packard and provide an IVUS patent license under a 1995 consent order would not result in a "material" financial impact, Boston Scientific says.